Total Clarity Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,172
Closed -$855K 192
2022
Q4
$855K Sell
9,172
-82
-0.9% -$7.91K 0.44% 59
2022
Q3
$883K Buy
9,254
+1,548
+20% +$153K 0.55% 53
2022
Q2
$714K Buy
7,706
+1,317
+21% +$129K 0.37% 63
2022
Q1
$647K Sell
6,389
-47
-0.7% -$4.94K 0.35% 75
2021
Q4
$664K Sell
6,436
-1
-0% -$92 0.3% 83
2021
Q3
$546K Buy
6,437
+151
+2% +$12.6K 0.26% 95
2021
Q2
$525K Buy
6,286
+150
+2% +$12.3K 0.29% 100
2021
Q1
$462K Buy
6,136
+500
+9% +$36.4K 0.27% 94
2020
Q4
$385K Sell
5,636
-2,690
-32% -$175K 0.27% 96
2020
Q3
$486K Sell
8,326
-5
-0.1% -$311 0.42% 68
2020
Q2
$541K Sell
8,331
-100
-1% -$6.3K 0.5% 56
2020
Q1
$500K Sell
8,431
-224
-3% -$15K 0.77% 39
2019
Q4
$643K Buy
+8,655
New +$608K 0.48% 49

Other funds holding CVS

Total Clarity Wealth Management's CVS Position: Q1 2023 in Review

Total Clarity Wealth Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 9,172 shares — an estimated $855K sold.

Total Clarity Wealth Management first reported a position in CVS in Q4 2019 and held it in 13 quarters. The position peaked at $883K in Q3 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Total Clarity Wealth Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Total Clarity Wealth Management sold 9,172 CVS Health shares in Q1 2023, an estimated $855K.
  • Total Clarity Wealth Management first reported a position in CVS Health in Q4 2019 and held it in 13 quarters.
  • Total Clarity Wealth Management's CVS Health position peaked at $883K in Q3 2022.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Total Clarity Wealth Management's 13F filing for Q1 2023, filed 4 May 2023.